Multiple cavitations in posterior reversible leukoencephalopathy syndrome associated with hemolytic-uremic syndrome

Brain and Development

Volumn 34, Issue 4, 2012, Pages 318-321

  Fujii, Katsunori ^a   Matsuo, Kaoru ^a   Takatani, Tomozumi ^a   Uchikawa, Hideki ^a   Kohno, Yoichi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cavitation; Hemolytic uremic syndrome; HUS; Posterior reversible leukoencephalopathy syndrome; PRES

Indexed keywords

ALANINE AMINOTRANSFERASE; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DISINTEGRIN; FRUCTOSE BISPHOSPHATE; GADOLINIUM; HEMOGLOBIN; METALLOPROTEINASE; MIDAZOLAM; SHIGA TOXIN; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACUTE KIDNEY FAILURE; ARTICLE; BLOOD EXAMINATION; BLOOD PRESSURE REGULATION; BRAIN DAMAGE; CASE REPORT; CHILD; DISEASE COURSE; ESCHERICHIA COLI INFECTION; HEMATOCHEZIA; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRESCHOOL CHILD; THROMBOCYTE COUNT; THROMBOCYTOPENIC PURPURA; UNCONSCIOUSNESS; UREA NITROGEN BLOOD LEVEL; VISUAL DISORDER;

CEREBRAL INFARCTION; CHILD, PRESCHOOL; ESCHERICHIA COLI INFECTIONS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MALE; OCCIPITAL LOBE; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME;

EID: 84858293639     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2011.06.003     Document Type: Article

References (11)

1. Hinchey J., Chaves C., Appignani B., Breen J., Pao L., Wang A., et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996, 334:494-500.
2. Antunes N.L., Small T.N., George D., Boulad F., Lis E., et al. Posterior leukoencephalopathy syndrome may not be reversible. Pediatr Neurol 1999, 20:241-243.
3. Bartynski W.S. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008, 29:1036-1042.
4. Ay H., Buonanno F.S., Schaefer P.W., Schaefer P.W., Schwamm L.H., Wu O., et al. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 1998, 51:1369-1376.
5. Koch S., Rabinstein A., Falcone S., Forteza A. Diffusion-weighted imaging shows cytotoxic and vasogenic edema in eclampsia. AJNR Am J Neuroradiol 2001, 22:1068-1070.
6. Moake J.L. Thrombotic microangiopathies. N Engl J Med 2002, 347:589-600.
7. Tarr P.I., Gordon C.A., Chandler W.L. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005, 365:1073-1086.
8. Gómez-Lado C., Martinón-Torres F., Alvarez-Moreno A., Eirís-Puñal J., Carreira-Sande N., Rodriguez-Nuñez A., et al. Reversible posterior leukoencephalopathy syndrome: an infrequent complication in the course of haemolytic-uremic syndrome. Rev Neurol 2007, 44:475-478.
9. Taylor M.B., Jackson A., Weller J.M. Dynamic susceptibility contrast enhanced MRI in reversible posterior leukoencephalopathy syndrome associated with haemolytic uraemic syndrome. Br J Radiol 2000, 73:438-442.
10. Bennett B., Booth T., Quan A. Late onset seizures, hemiparesis, and blindness in hemolytic uremic syndrome. Clin Nephrol 2003, 59:196-200.
11. Ducros A., Boukobza M., Porcher R., Sarov M., Valade D., Bousser M.G. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 2007, 130:3091-3101.